Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 7 articles: HTML format

Single Articles

January 2023
1. JONES RR, Fisher JA, Medgyesi DN, Buller ID, et al
   Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a U.S. cohort.
   J Natl Cancer Inst. 2023 Jan 12:djad004. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2022
2. SUNG H, Siegel RL, Hyun N, Miller KD, et al
   Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers.
   J Natl Cancer Inst. 2022;114:1095-1108.
   PubMed     Abstract available
   
   
   June 2022
3. ROBERTI S, van Leeuwen FE, Ronckers CM, Krul IM, et al
   Radiotherapy-related dose and irradiated volume effects on breast cancer risk among Hodgkin lymphoma survivors.
   J Natl Cancer Inst. 2022 Jun 30. pii: 6623416. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. CASTILHO JL, Bian A, Jenkins CA, Shepherd BE, et al
   CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
   J Natl Cancer Inst. 2022;114:854-862.
   PubMed     Abstract available
   
   
   July 2021
5. JANELSINS MC, Mohamed M, Peppone LJ, Magnuson A, et al
   Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients with Lymphoma Treated with Chemotherapy.
   J Natl Cancer Inst. 2021 Jul 13. pii: 6320069. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. VARDY JL, Fardell J
   Understanding Longitudinal Changes in Cognitive Function in Lymphoma Patients: Where to Next?
   J Natl Cancer Inst. 2021 Jul 13. pii: 6320068. doi: 10.1093.
   PubMed    
   
   
   May 2021
7. FIDLER-BENAOUDIA MM, Oeffinger KC, Yasui Y, Robison LL, et al
   A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom.
   J Natl Cancer Inst. 2021;113:562-571.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: